Olmutinib
CAS: 1353550-13-6
Ref. 3D-DEC55013
| 5mg | Descatalogado | ||
| 10mg | Descatalogado | ||
| 25mg | Descatalogado | ||
| 50mg | Descatalogado | ||
| 100mg | Descatalogado |
Información del producto
Nombre:
Olmutinib
Sinónimos:
- N-[3-[[2-[[4-(4-Methyl-1-piperazinyl)phenyl]amino]thieno[3,2-d]pyrimidin-4-yl]oxy]phenyl]-2-propenamide
- 2-Propenamide, N-[3-[[2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]thieno[3,2-d]pyrimidin-4-yl]oxy]phenyl]-
- HM 61713
- BI 1482694
Descripción:
Olmutinib is a small molecule that inhibits the activity of the protein kinase AXL, which is a key regulator of T-cell activation. It has been shown to inhibit tumor growth in animal models and may be effective against other cancers as well as autoimmune diseases. Olmutinib has also been shown to inhibit the proliferation of rat liver microsomes and stabilize complexes with low potency. The LC-MS/MS method used to identify the protein target of olmutinib was based on stable complexes with low potency. This method can be used for the development of new drugs that target this protein kinase.
Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:
Propiedades químicas
Peso molecular:
486.59 g/mol
Fórmula:
C26H26N6O2S
Pureza:
Min. 95%
MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:
